3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 23 0 0 0 0 0 0 0999 V2000
-4.0056 -0.0343 0.7690 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.5660 1.5718 0.4467 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.5103 0.5958 -1.2572 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.0531 -1.7892 -0.4547 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9655 -0.6513 -0.4421 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7072 0.9562 0.0035 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3994 -0.9255 0.4161 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6830 -0.1106 0.3886 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1772 0.6755 0.1187 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8052 -1.2612 0.1917 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0090 1.5632 -0.2663 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6115 -0.3226 0.1793 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8736 -0.6380 -0.0664 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9833 0.3702 -0.0270 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0224 -1.5253 1.2336 H 0 0 0 0 0 0 0 0 0 0 0 0
2.5440 -2.1825 -0.3396 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1049 1.1007 -0.2790 H 0 0 0 0 0 0 0 0 0 0 0 0
4.2883 0.6233 1.2090 H 0 0 0 0 0 0 0 0 0 0 0 0
3.0777 2.5074 0.2850 H 0 0 0 0 0 0 0 0 0 0 0 0
3.0587 1.8127 -1.3331 H 0 0 0 0 0 0 0 0 0 0 0 0
4.7858 -1.2321 -0.2721 H 0 0 0 0 0 0 0 0 0 0 0 0
0.2706 -1.9146 0.5978 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.5642 0.8354 0.7353 H 0 0 0 0 0 0 0 0 0 0 0 0
1 14 1 0 0 0 0
2 14 1 0 0 0 0
3 14 1 0 0 0 0
4 13 2 0 0 0 0
5 9 1 0 0 0 0
5 10 1 0 0 0 0
5 21 1 0 0 0 0
6 11 1 0 0 0 0
6 12 2 0 0 0 0
7 8 1 0 0 0 0
7 12 1 0 0 0 0
7 22 1 0 0 0 0
8 13 1 0 0 0 0
8 23 1 0 0 0 0
9 11 1 0 0 0 0
9 17 1 0 0 0 0
9 18 1 0 0 0 0
10 12 1 0 0 0 0
10 15 1 0 0 0 0
10 16 1 0 0 0 0
11 19 1 0 0 0 0
11 20 1 0 0 0 0
13 14 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2,2,2-trifluoro-N'-(1,2,3,6-tetrahydropyrazin-5-yl)acetohydrazide
4.2 InChl
InChI=1S/C6H9F3N4O/c7-6(8,9)5(14)13-12-4-3-10-1-2-11-4/h10H,1-3H2,(H,11,12)(H,13,14)
4.3 InChlKey
RKIDLJBEMIARHI-UHFFFAOYSA-N
4.4 Canonical SMILES
C1CN=C(CN1)NNC(=O)C(F)(F)F
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病